Skip to main content
Premium Trial:

Request an Annual Quote

FDA Open to Suggestions for Overcoming Drug Development Obstacles

NEW YORK, April 22 (GenomeWeb News) - The US Food and Drug Administration has established a public docket to obtain information on the major hurdles in drug, device, and biologic development, and to solicit proposed solutions.

 

The docket encourages input from industry, patients, academics, investors, and all other interested parties to be submitted via letter or electronically by July 30. All submitted material will be publicly available.

 

The FDA first outlined the initiative in a March 16 white paper that noted a decline in the number of new drug, biologic, and medical device applications, despite the recent boom in genomics, proteomics, bioinformatics and related technologies.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.